As a route of administration, inhalation delivery might be considered onerous as biopharma companies are presented with unique and technical challenges to blend formulation development and medical device engineering into a product with high patient compliance. This complexity often dissuades development companies from inhalation delivery either for the respiratory or systemic disease target. This webinar sets out to demonstrate what solutions exist today to allay potential development concerns.
Simon Moore, Global Lead of Inhalation Sciences and Engineering, Covance
To provide global leadership, strategic direction and management to expand the Covance position as a leading provider of non-clinical services for inhaled product development. This will be facilitated through proactive interactions with clients and promotion of Covance Inhalation Science and Engineering as a global business and through best practice techniques for study conduct across sites, as well as demonstration of scientific excellence in Inhalation Science across the global organization.Message Presenter
Who Should Attend?
This webinar will appeal to individuals with the following or related job titles:
- Heads of Preclinical R&D
- Lead Scientists
- Project managers
- Preclinical/ nonclinical experts
- Preclinical/ nonclinical scientists
- Those who want to know more about inhalation delivery
What You Will Learn
In this webinar, participants will learn about:
- Solutions to overcome inhaled product development complexity
- Answers to sponsors’ commonly asked inhaled product development questions
Covance is a business segment of LabCorp, a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Employing over 21,000 people worldwide, we are the world’s most comprehensive CRO, dedicated to improving health and improving lives.
Covance is a global leader in nonclinical safety assessment, clinical trial testing and clinical trial management services. Our unique perspectives are based on decades of scientific, medical, and regulatory expertise. We generate more safety and efficacy data to support drug approvals than any other company, supporting our clients’ complete lifecycle management.
Together with our clients, Covance transforms today’s healthcare challenges into tomorrow’s solutions. Visit us at www.covance.com.